Ilaria Cavallari

Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub‐Analysis From the PREFER in AF ( <i>PRE</i> vention o <i>F</i> Thromboembolic Events– <i>E</i> uropean <i>R</i> egistry in <i>A</i> trial <i>F</i> ibrillation)

Giuseppe Patti, Markus Lucerna, Ladislav Pecen et al. · Journal of the American Heart Association · 2017 · 169 citations · Full text

Medicine, Cardiology, Geriatric Medicine +17

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

Michael R. McClung, Michelle L. O’Donoghue, Socrates E. Papapoulos et al. · The Lancet Diabetes & Endocrinology · 2019 · 169 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +10

Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation

Giuseppe Patti, Markus Lucerna, Ilaria Cavallari et al. · Journal of the American College of Cardiology · 2017 · 85 citations · Full text

Medicine, Cardiology, Internal Medicine +16

The left atrial appendage: from embryology to prevention of thromboembolism

Giuseppe Patti, Vittorio Pengo, Rossella Marcucci et al. · European Heart Journal · 2016 · 78 citations · Full text

Medicine, Cardiology, Surgery +17

Impact of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio on 5-Year Clinical Outcomes of Patients with Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention

Edoardo Bressi, Fabio Mangiacapra, Elisabetta Ricottini et al. · Journal of Cardiovascular Translational Research · 2018 · 52 citations

Medicine, Cardiology, Hematology +16